메뉴 건너뛰기




Volumn 9, Issue 1, 2010, Pages 33-40

Dapsone gel 5% in combination with adapalene gel 0.1%, benzoyl peroxide gel 4% or moisturizer for the treatment of acne vulgaris: A 12-week, randomized, double-blind study

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; BENZOYL PEROXIDE; CETAPHIL; DAPSONE; UNCLASSIFIED DRUG; DERMATOLOGICAL AGENT; KERATOLYTIC AGENT; NAPHTHALENE DERIVATIVE;

EID: 77449116451     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (34)

References (17)
  • 1
    • 0442313538 scopus 로고    scopus 로고
    • Physiopathology of acne vulgaris: Recent data, new understanding of the treatments
    • Pawin H, Beylot C, Chivot M, et al. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol. 2004:14(1):4-12.
    • (2004) Eur J Dermatol , vol.14 , Issue.1 , pp. 4-12
    • Pawin, H.1    Beylot, C.2    Chivot, M.3
  • 2
    • 0642337440 scopus 로고    scopus 로고
    • Pathogenesis of acne: Recent research advances
    • Harper JC, Thiboutot DM. Pathogenesis of acne: Recent research advances. Adv Dermatol. 2003;19:1-10.
    • (2003) Adv Dermatol , vol.19 , pp. 1-10
    • Harper, J.C.1    Thiboutot, D.M.2
  • 3
    • 0038729440 scopus 로고    scopus 로고
    • Management of acne: A report from a Global Alliance to Improve Outcomes in Acne
    • and Global Alliance to Improve Outcomes in Acne.
    • Gollnick H, Cunliffe W, Berson D, et al; and Global Alliance to Improve Outcomes in Acne. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):1S-37S.
    • (2003) J Am Acad Dermatol , vol.49 , Issue.1 SUPPL.
    • Gollnick, H.1    Cunliffe, W.2    Berson, D.3
  • 4
    • 33947185823 scopus 로고    scopus 로고
    • Guidelines of care for acne vulgaris management
    • American Academy of Dermatology/American Academy of Dermatology Association
    • Strauss JS, Krowchuk DP, Leyden JJ, et al; American Academy of Dermatology/American Academy of Dermatology Association. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56(4):651-663.
    • (2007) J Am Acad Dermatol , vol.56 , Issue.4 , pp. 651-663
    • Strauss, J.S.1    Krowchuk, D.P.2    Leyden, J.J.3
  • 5
    • 0042328102 scopus 로고    scopus 로고
    • A review of the use of combination therapies for the treatment of acne vulgaris
    • Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49(3 Suppl):S200-S210.
    • (2003) J Am Acad Dermatol , vol.49 , Issue.3 SUPPL.
    • Leyden, J.J.1
  • 6
    • 0021358999 scopus 로고
    • Dermatitis herpetiformis: Effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity
    • Kazmierowski JA, Ross JE, Peizner DS, Wuepper KD. Dermatitis herpetiformis: Effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity. J Clin Immunol. 1984;4(1):55-64.
    • (1984) J Clin Immunol , vol.4 , Issue.1 , pp. 55-64
    • Kazmierowski, J.A.1    Ross, J.E.2    Peizner, D.S.3    Wuepper, K.D.4
  • 7
    • 0024165477 scopus 로고
    • Dapsone inhibits LTB4 binding and bioresponse at the cellular and physiologic levels
    • Maloff BL, Fox D, Bruin E, Di Meo TM. Dapsone inhibits LTB4 binding and bioresponse at the cellular and physiologic levels. Eur J Pharmacol. 1988;158(1-2):85-89.
    • (1988) Eur J Pharmacol , vol.158 , Issue.1-2 , pp. 85-89
    • Maloff, B.L.1    Fox, D.2    Bruin, E.3    Di Meo, T.M.4
  • 8
    • 0031442335 scopus 로고    scopus 로고
    • Anti-inflammatory action of dapsone: Inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction
    • Debol SM, Herron MJ, Nelson RD. Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction. J Leukoc Biol. 1997;62(6):827-836.
    • (1997) J Leukoc Biol , vol.62 , Issue.6 , pp. 827-836
    • Debol, S.M.1    Herron, M.J.2    Nelson, R.D.3
  • 9
    • 0001035601 scopus 로고
    • The treatment of acne vulgaris with dapsone
    • Ross CM. The treatment of acne vulgaris with dapsone. Br J Dermatol. 1961;73:367 370.
    • (1961) Br J Dermatol , vol.73 , Issue.367 , pp. 370
    • Ross, C.M.1
  • 11
    • 0019772864 scopus 로고
    • Experience with Disulone in the treatment of severe nodular acne
    • in French
    • Geniaux M, Meraud JP, Texier L. Experience with Disulone in the treatment of severe nodular acne [in French]. LARC Med. 1981;1:67.
    • (1981) LARC Med , vol.1 , pp. 67
    • Geniaux, M.1    Meraud, J.P.2    Texier, L.3
  • 12
    • 0034861699 scopus 로고    scopus 로고
    • Dapsone and sulfones in dermatology: Overview and update
    • Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: Overview and update. J Am Acad Dermatol. 2001;45(3):420-434.
    • (2001) J Am Acad Dermatol , vol.45 , Issue.3 , pp. 420-434
    • Zhu, Y.I.1    Stiller, M.J.2
  • 13
    • 34547621610 scopus 로고    scopus 로고
    • Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris
    • Thiboutot DM, Willmer J, Sharata H, et al. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris. Clin Pharmacokinet. 2007;46(8):697-712.
    • (2007) Clin Pharmacokinet , vol.46 , Issue.8 , pp. 697-712
    • Thiboutot, D.M.1    Willmer, J.2    Sharata, H.3
  • 14
    • 33847020777 scopus 로고    scopus 로고
    • Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris
    • for United States/Canada Dapsone Gel Study Group
    • Draelos ZD, Carter E, Maloney JM, et al. for United States/Canada Dapsone Gel Study Group. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439.e1-439.e10.
    • (2007) J Am Acad Dermatol , vol.56 , Issue.3
    • Draelos, Z.D.1    Carter, E.2    Maloney, J.M.3
  • 15
    • 33847064403 scopus 로고    scopus 로고
    • Five percent dapsone topical gel: Safety and efficacy with long-term (one year) treatment for acne vulgaris
    • Roberts J, Maloney M, Ling M, Lucky AW. Five percent dapsone topical gel: Safety and efficacy with long-term (one year) treatment for acne vulgaris. J Am Acad Dermatol. 2005;52:5.
    • (2005) J Am Acad Dermatol , vol.52 , pp. 5
    • Roberts, J.1    Maloney, M.2    Ling, M.3    Lucky, A.W.4
  • 16
    • 20444441044 scopus 로고    scopus 로고
    • Cumulative irritation potential of adapalene 0.1% cream and gel compared to tazarotene cream 0.05% and 0.1%
    • Dosik JS, Homer K, Arsonnaud S. Cumulative irritation potential of adapalene 0.1% cream and gel compared to tazarotene cream 0.05% and 0.1%. Cutis. 2005;75(5):289-293.
    • (2005) Cutis , vol.75 , Issue.5 , pp. 289-293
    • Dosik, J.S.1    Homer, K.2    Arsonnaud, S.3
  • 17
    • 80053016786 scopus 로고    scopus 로고
    • package insert. Fort Worth (TX): Galderma Laboratories, L.P.
    • Differin® Gel, 0.1% [package insert]. Fort Worth (TX): Galderma Laboratories, L.P.; 2003.
    • (2003) Differin® Gel, 0.1%


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.